日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Creatinine/Cystatin C Ratio as a Surrogate Marker for Sarcopenia in Hepatitis-C-Associated Liver Cirrhosis After Achieving a Sustained Virologic Response

肌酐/胱抑素C比值作为丙型肝炎相关肝硬化患者获得持续病毒学应答后肌少症的替代标志物

期刊:Current Issues in Molecular Biology
影响因子:3
doi:10.3390/cimb48020222
Koizumi, Aritoshi; Namisaki, Tadashi; Shibamoto, Akihiko; Inoue, Takashi; Asada, Shohei; Matsuda, Takuya; Iwai, Satoshi; Tsuji, Yuki; Fujinaga, Yukihisa; Nishimura, Norihisa; Sato, Shinya; Kitagawa, Koh; Kaji, Kosuke; Mitoro, Akira; Asada, Kiyoshi; Takaya, Hiroaki; Noguchi, Ryuichi; Yoshiji, Hitoshi
微生物学
肝炎
肝硬化
发表日期：2026
文献求助 收藏

Third-Generation Narrow-Band Imaging Versus White-Light Imaging for the Detection of Early Gastric Cancer: A Randomized Controlled Study

第三代窄带成像与白光成像在早期胃癌检测中的比较：一项随机对照研究

期刊:DEN Open
影响因子:1.5
doi:10.1002/deo2.70288
Fujinaga, Yukihisa; Mori, Hitoshi; Takami, Masayoshi; Masuda, Hiroyuki; Hanatani, Jun-Ichi; Iwai, Satoshi; Asada, Shohei; Shibamoto, Akihiko; Tsuji, Yuki; Kitagawa, Koh; Nishimura, Norihisa; Sato, Shinya; Kaji, Kosuke; Namisaki, Tadashi; Mitoro, Akira; Yoshiji, Hitoshi
胃癌
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Creatinine-to-Cystatin C Ratio Combined with FIB-4 and ELF for Noninvasive Fibrosis Assessment in MASLD

肌酐/胱抑素C比值联合FIB-4和ELF用于MASLD患者的无创纤维化评估

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms26199560
Oyama, Masafumi; Namisaki, Tadashi; Shibamoto, Akihiko; Iwai, Satoshi; Takami, Masayoshi; Tsuji, Yuki; Fujinaga, Yukihisa; Takaya, Hiroaki; Inoue, Takashi; Nishimura, Norihisa; Sato, Shinya; Kitagawa, Koh; Kaji, Kosuke; Mitoro, Akira; Asada, Kiyoshi; Masuda, Hiroyuki; Hanatani, Junichi; Yoshiji, Hitoshi
发表日期：2025
文献求助 收藏

Clinical Significance of Marginal Zinc Deficiency as a Predictor of Covert Hepatic Encephalopathy in Patients with Liver Cirrhosis.

边缘性锌缺乏作为肝硬化患者隐匿性肝性脑病预测指标的临床意义

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms26094184
Matsuda Takuya, Namisaki Tadashi, Shibamoto Akihiko, Asada Shohei, Tomooka Fumimasa, Kubo Takahiro, Koizumi Aritoshi, Tanaka Misako, Iwai Satoshi, Inoue Takashi, Tsuji Yuki, Fujinaga Yukihisa, Nishimura Norihisa, Sato Shinya, Kitagawa Koh, Kaji Kosuke, Mitoro Akira, Asada Kiyoshi, Takaya Hiroaki, Noguchi Ryuichi, Akahane Takemi, Yoshiji Hitoshi
肝硬化
神经科学
发表日期：2025
文献求助 收藏

Site of Biopsy and Its Accuracy in Preoperative Diagnosis of Superficial Nonampullary Duodenal Epithelial Tumors: Retrospective Study

活检部位及其在浅表性非壶腹部十二指肠上皮肿瘤术前诊断中的准确性：回顾性研究

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm14082579
Fujinaga, Yukihisa; Mitoro, Akira; Mori, Hitoshi; Iwai, Satoshi; Kubo, Takahiro; Tanaka, Misako; Koizumi, Aritoshi; Tomooka, Fumimasa; Asada, Shohei; Kitagawa, Koh; Nishimura, Norihisa; Sato, Shinya; Kaji, Kosuke; Namisaki, Tadashi; Yoshiji, Hitoshi
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Efficacy of an Endoscopic Device Integrating a Sphincterotome and a Dilation Balloon Catheter for the Treatment of Choledocholithiasis (with Video)

内镜下括约肌切开刀与扩张球囊导管联合装置治疗胆总管结石的疗效（附视频）

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm14175930
Hanatani, Jun-Ichi; Kitagawa, Koh; Asada, Shohei; Motokawa, Yuki; Osaki, Yui; Iwata, Tomihiro; Fujinaga, Yukihisa; Nishimura, Norihisa; Kaji, Kosuke; Sato, Shinya; Namisaki, Tadashi; Mitoro, Akira; Yoshiji, Hitoshi
发表日期：2025
文献求助 收藏

Marked Increase in Zinc Concentration of Ascitic Fluid After Cell-free and Concentrated Ascites Reinfusion Therapy in Patients With Cirrhotic Refractory Ascites: A Retrospective Observational Study

无细胞浓缩腹水回输治疗后肝硬化难治性腹水患者腹水中锌浓度显著升高：一项回顾性观察研究

期刊:In Vivo
影响因子:1.8
doi:10.21873/invivo.14157
Namisaki, Tadashi; Shibamoto, Akihiko; Iwai, Satoshi; Takami, Masayoshi; Masuda, Hiroyuki; Tsuji, Yuki; Fujinaga, Yukihisa; Takaya, Hiroaki; Inoue, Takashi; Sato, Shinya; Kitagawa, Koh; Nishimura, Norihisa; Kaji, Kosuke; Mitoro, Akira; Asada, Kiyoshi; Yoshiji, Hitoshi
细胞生物学
肝硬化
发表日期：2025
文献求助 收藏

Impact of the COVID-19 pandemic on the treatment of acute cholangitis caused by choledocholithiasis: A single-center retrospective study in Japan

COVID-19 大流行对胆总管结石所致急性胆管炎治疗的影响：日本单中心回顾性研究

期刊:DEN Open
影响因子:1.5
doi:10.1002/deo2.371
Hanatani, Jun-Ichi; Kitagawa, Koh; Tomooka, Fumimasa; Asada, Shohei; Mitoro, Akira; Fujinaga, Yukihisa; Nishimura, Norihisa; Sato, Shinya; Shibamoto, Akihiko; Fujimoto, Yuki; Kubo, Takahiro; Iwai, Satoshi; Tsuji, Yuki; Namisaki, Tadashi; Akahane, Takemi; Kaji, Kosuke; Tanaka, Misako; Koizumi, Aritoshi; Yorioka, Nobuyuki; Matsuda, Takuya; Masuda, Hiroyuki; Takami, Masayoshi; Kikuchi, Mayuko; Kawanishi, Mariya; Ohoka, Kazutaka; Watanabe, Daisuke; Kawasaki, Akane; Yoshiji, Hitoshi
发表日期：2025
文献求助 收藏

Unilateral drainage and chemotherapy prolong the patency of a plastic stent placed above the sphincter of Oddi in patients with malignant hilar biliary obstruction

单侧引流和化疗可延长置于奥迪氏括约肌上方的塑料支架在恶性肝门部胆道梗阻患者中的通畅时间。

期刊:DEN Open
影响因子:1.5
doi:10.1002/deo2.404
Tomooka, Fumimasa; Kitagawa, Koh; Mitoro, Akira; Fujinaga, Yukihisa; Nishimura, Norihisa; Namisaki, Tadashi; Akahane, Takemi; Kaji, Kosuke; Asada, Shohei; Sato, Shinya; Hanatani, Jun-Ichi; Mori, Hitoshi; Motokawa, Yuki; Iwata, Tomihiro; Kachi, Hiroki; Osaki, Yui; Yoshiji, Hitoshi
发表日期：2025
文献求助 收藏

The Ratio of von Willebrand Factor Antigen to ADAMTS13 Activity: Usefulness as a Prognostic Biomarker in Acute-on-Chronic Liver Failure

血管性血友病因子抗原与ADAMTS13活性的比值：作为急性加重型慢性肝衰竭预后生物标志物的应用价值

期刊:Biology-Basel
影响因子:3.5
doi:10.3390/biology12020164
Takaya, Hiroaki; Namisaki, Tadashi; Enomoto, Masahide; Kubo, Takahiro; Tsuji, Yuki; Fujinaga, Yukihisa; Nishimura, Norihisa; Kaji, Kosuke; Kawaratani, Hideto; Moriya, Kei; Akahane, Takemi; Matsumoto, Masanori; Yoshiji, Hitoshi
肝衰竭
毒理研究
ADA
发表日期：2023
文献求助 收藏